Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Mol Psychiatry. 2013 Dec 17;19(2):168–174. doi: 10.1038/mp.2013.166

Table 1.

Description of COGENT cohorts.

Dataseta Genotyping
Platform
Concordanceb Genotypes
after QC
N %Male Mean Age (SD) Lambdac
Germany Illumina OE d 99.50% 1,078,289 594 51% 54.0 (15.0) 1.01
LOGOS Illumina OE 99.40% 835,287 802 100% 22.3 (3.8) 1.03
IBG Affymetrix 6.0 99.59% 938,800 299 77% 15.9 (1.5) 1.00
LBC1936 Illumina 610 99.60% 1,058,722 1005 51% 69.5 (0.8) 1.01
TOP Affymetrix 6.0 94.23% 917,315 351 48% 34.2 (9.8) 1.01
NCNG Illumina 610 99.40% 944,135 629 32% 47.6 (18.3) 1.00
Manchester Illumina 610 99.60% 1,059,916 697 30% 67.7 (2.8) 1.01
HBCS Illumina 610 99.60% 1,043,380 318 100% 67.7 (2.3) 1.00
ZHH Illumina OE 99.40% 1,043,785 201 47% 39.1 (1.8) 1.06
a

Detailed descriptions of each cohort provided in Supplementary Text.

b

Concordance between imputed and genotyped SNPs.

c

Lambda to refers λGC,, a measure of the degree of statistical inflation in genomewide association studies.

d

OE refers to the Illumina OmniExpress genotyping bead chip